Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

2 clinical studies listed.

Filters:

Lou Gehrig Disease

Tundra lists 2 Lou Gehrig Disease clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ENROLLING BY INVITATION

NCT05725759

Rehabilitation and Exercise in SOD1-ALS TOfersen REcipients (RESTORE)

The primary objective of this study is to document and describe the effects of a personalized rehabilitation program for patients with SOD1 ALS participating in the tofersen expanded access program. Participants currently receiving tofersen treatment will be referred to outpatient physical and/or occupational therapy. Participants will have an initial assessment performed and an individualized rehabilitation program will be prescribed. Each participant is encouraged to follow the prescribed recommendations that will include scheduled outpatient therapy sessions, functional assessments, and/or a home-based rehabilitation program. Functional assessments will be done at a minimum of every three months.

Gender: All

Ages: 18 Years - Any

Updated: 2026-11-09

1 state

Amyotrophic Lateral Sclerosis
Lou Gehrig Disease
Familial Amyotrophic Lateral Sclerosis
+2
NOT YET RECRUITING

NCT06315608

MRG-001 in Patients With Amyotrophic Lateral Sclerosis

The proposed study is an Open-Label, Single-Dose Study to Assess the Safety, and Pharmacodynamics (PD) signals of MRG-001 in Patients with Amyotrophic Lateral Sclerosis (ALS). MRG-001 will be administered subcutaneously 3 times per week for 2 weeks. This cycle will be repeated for 3 months. In total, patients are expected to receive 18 injections over the span of 3 months.

Gender: All

Ages: 18 Years - 75 Years

Updated: 2024-08-23

Amyotrophic Lateral Sclerosis
Lou Gehrig Disease
Motor Neuron Disease
+1